Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02329847 |
Title | Pharmacokinetic and Pharmacodynamic Study to Evaluate Safety and Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Janssen Research & Development, LLC |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | TUR | POL | ISR | ESP | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
New York | New York | United States | Details | |||
Bedford Park | Australia | Details | ||||
Darlinghurst | Australia | Details | ||||
Woolloongabba | Australia | Details | ||||
Haifa | Israel | Details | ||||
Jeursalem | Israel | Details | ||||
Ramat Gan | Israel | Details | ||||
Tel Aviv | Israel | Details | ||||
Chorzow | Poland | Details | ||||
Gdansk | Poland | Details | ||||
Krakow | Poland | Details | ||||
Wroclaw | Poland | Details | ||||
Barcelona | Spain | Details | ||||
Madrid | Spain | Details | ||||
Salamanca | Spain | Details | ||||
Ankara | Turkey | Details | ||||
Istanbul | Turkey | Details | ||||
Izmir | Turkey | Details |